Cover Image
市場調查報告書

全球智慧藥丸市場考察,機會分析,市場佔有率,預測

Global Smart Pill Market Research Report,Insights, Opportunity, Analysis, Market Shares And Forecast 2017 - 2023

出版商 Occams Business Research & Consulting Pvt. Ltd. 商品編碼 607604
出版日期 內容資訊 英文 190 Pages
商品交期: 請詢問到貨日
價格
Back to Top
全球智慧藥丸市場考察,機會分析,市場佔有率,預測 Global Smart Pill Market Research Report,Insights, Opportunity, Analysis, Market Shares And Forecast 2017 - 2023
出版日期: 2018年02月22日 內容資訊: 英文 190 Pages
簡介

本報告提供全球智慧藥丸市場相關調查分析,市場概要,市場決策要素,市場區隔,競爭情形,各地區的分析,企業簡介等系統性資訊。

第1章 簡介

第2章 市場概要

  • 市場:演進與轉移
  • 市場定義、範圍
  • 產業結構
  • 法律規範
  • 綜合市場分析
  • 評估分析
  • 策略分析
  • 競爭分析
  • 策略性建議主要的結論

第3章 市場決策要素

  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 市場課題

第4章 市場區隔

  • 市場:各用途

第5章 競爭情形

  • 主要策略

第6章 各地區分析

  • 決策依據的資料庫、估計手法
  • 各市場區隔的比較分析
  • 機會矩陣
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第7章 企業簡介

  • ACAMP (加拿大)
  • BIO-IMAGES RESEARCH (英國)
  • BOSTON SCIENTIFIC CORPORATION (美國)
  • CAPSOVISION INC. (美國)
  • CERNER (美國)
  • CHONGQING JINSHAN SCIENCE & TECHNOLOGY GROUP CO. LTD. (中國)
  • FUJIFILM Holdings (日本)
  • GE HEALTHCARE (英國)
  • GIVEN IMAGING INC. (以色列)
  • INTROMEDIC CO. LTD. (韓國)
  • KARL STORZ GMBH & CO. KG (德國)
  • MEDIMETRICS (墨西哥)
  • Olympus Corporation (日本)
  • PENTAX MEDICAL COMPANY (美國)
  • PROTEUS DIGITAL HEALTH INC. (美國)
目錄
Product Code: HAD-9370218

Smart pills are ingestible capsules which are used to track and record physiological activities and gives full information of the gastrointestinal tract of the human body. The global smart pill market is expected to rise with the CAGR of about 16% during the forecast period 2016-2023. Increasing geriatric population is one of the major driving factors which contributes to the growth of global smart pill market during the forecast period. Also, FDA approvals and CE Mark for smart pills and cancer awareness screening programs promotes the growth of global smart pill market. However, technological limitations in smart pills and lengthy approval process of the product are some of the major factors restraining the growth of global smart pill market during the forecast period.

Geographically, the global smart pill market report has been segmented into North America, Asia Pacific, Europe, and Rest of World. North America accounted for the largest market revenue share in the global smart pill market in 2016 and is expected to dominate the market during the forecast period owing to technological advancements in healthcare facilities and increasing incidences of colorectal cancer. However, Asia Pacific is expected to be the fastest growing region in global smart pill market during the forecast period due to increasing geriatric population. Countries such as China, India, Japan and South Korea majorly contribute to the fastest growth rate of Asia Pacific smart pill market during the forecast period.

The growth in the global smart pill market is also influenced by the presence of major market players such as Boston Scientific Corporation (United States), GE Healthcare (United Kingdom), Olympus Corporation (Japan), Chongqing Jinshan Science & Technology Group Co. Ltd. (China), Intromedic Co. Ltd, (South Korea), etc. These leading players are adopting different strategies to increase their market share and are trying to penetrate the market in developing economies.

Global smart pill market report covers segments such as application. Report further covers sub-segment of application which includes capsule endoscopy, drug delivery and patient monitoring. Capsule endoscopy segment held the largest market revenue share for the global smart pill market in 2016 and is expected to dominate the market during the forecast period due to disposable nature of capsules as well as its repeated usage. This is expected to contribute towards largest market revenue share of capsule endoscopy in applications for the global smart pill market during the forecast period.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

  • 2.1. GLOBAL SMART PILL MARKET: EVOLUTION & TRANSITION
  • 2.2. MARKET DEFINITION & SCOPE
  • 2.3. INDUSTRY STRUCTURE
  • 2.4. REGULATORY FRAMEWORK
  • 2.5. TOTAL MARKET ANALYSIS
    • 2.5.1. TOP 5 FINDINGS
    • 2.5.2. TOP 5 OPPORTUNITY MARKETS
    • 2.5.3. TOP 5 COMPANIES
    • 2.5.4. TOP 3 COMPETITIVE STRATEGIES
  • 2.6. ESTIMATION ANALYSIS
  • 2.7. STRATEGIC ANALYSIS
    • 2.7.1. INVESTMENT VS. ADOPTION MODEL
    • 2.7.2. 360-DEGREE INDUSTRY ANALYSIS
    • 2.7.3. PORTERS 5 FORCE MODEL
    • 2.7.4. SEE-SAW ANALYSIS
    • 2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
  • 2.8. COMPETITIVE ANALYSIS
    • 2.8.1. KEY STRATEGIES & ANALYSIS
    • 2.8.2. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
  • 2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
    • 2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
    • 2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
    • 2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS
    • 3.1.1. INCREASING INCIDENCES OF DISEASES
    • 3.1.2. FDA APPROVALS AND CE MARK FOR SMART PILLS
    • 3.1.3. HIGH CANCER SCREENING AWARENESS PROGRAMS
    • 3.1.4. INCREASE IN AGEING POPULATION
  • 3.2. MARKET RESTRAINTS
    • 3.2.1. TECHNOLOGICAL INCOMPETENCE
    • 3.2.2. LENGTHY PRODUCT APPROVAL PROCESS
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. NEED FOR RAPID DRUG DEVELOPMENT PROCESS
    • 3.3.2. TECHNOLOGICAL ADVANCEMENTS IN CAPSULE ENDOSCOPES
  • 3.4. MARKET CHALLENGES
    • 3.4.1. REQUIREMENT OF TRAINING FOR PROFESSIONALS
    • 3.4.2. HUGE INVESTMENT COST OF SMART PILL

4. MARKET SEGMENTATION

  • 4.1. GLOBAL SMART PILL MARKET BY APPLICATION
    • 4.1.1. MARKET DEFINITION AND SCOPE
    • 4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.1.4. OPPORTUNITY MATRIX
    • 4.1.5. MARKET SEGMENTATION
      • 4.1.5.1. GLOBAL CAPSULE ENDOSCOPY MARKET
        • 4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.1.3. KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.1.4. KEY CONCLUSIONS
      • 4.1.5.2. GLOBAL DRUG DELIVERY MARKET
        • 4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.2.3. KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.2.4. KEY CONCLUSIONS
      • 4.1.5.3. GLOBAL PATIENT MONITORING MARKET
        • 4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.3.3. KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.3.4. KEY CONCLUSIONS

5. COMPETITIVE LANDSCAPE

  • 5.1. KEY STRATEGIES
    • 5.1.1. LIST OF MERGERS AND ACQUISITION
    • 5.1.2. LIST OF JOINT VENTURES
    • 5.1.3. LIST OF PRODUCT LAUNCHES
    • 5.1.4. LIST OF PARTNERSHIPS

6. GEOGRAPHIC ANALYSIS

  • 6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
  • 6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
  • 6.3. OPPORTUNITY MATRIX
  • 6.4. GLOBAL SMART PILL MARKET BY REGION 2014-2023 ($ MILLION)
    • 6.4.1. NORTH AMERICA
      • 6.4.1.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.1.2. TOP COUNTRY ANALYSIS
        • 6.4.1.2.1. U.S.
          • 6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.1.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.1.2.1.3. KEY CONCLUSIONS
        • 6.4.1.2.2. CANADA
          • 6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.2.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.1.2.2.3. KEY CONCLUSIONS
    • 6.4.2. EUROPE
      • 6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.2.2. TOP COUNTRY ANALYSIS
        • 6.4.2.2.1. UK
          • 6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.1.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.1.3. KEY CONCLUSIONS
        • 6.4.2.2.2. FRANCE
          • 6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.2.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.2.3. KEY CONCLUSIONS
        • 6.4.2.2.3. GERMANY
          • 6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.3.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.3.3. KEY CONCLUSIONS
        • 6.4.2.2.4. SPAIN
          • 6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.4.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.4.3. KEY CONCLUSIONS
        • 6.4.2.2.5. REST OF EUROPE
          • 6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.5.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.5.3. KEY CONCLUSIONS
    • 6.4.3. ASIA PACIFIC
      • 6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.3.2. TOP COUNTRY ANALYSIS
        • 6.4.3.2.1. CHINA
          • 6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.1.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.1.3. KEY CONCLUSIONS
        • 6.4.3.2.2. INDIA
          • 6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.2.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.2.3. KEY CONCLUSIONS
        • 6.4.3.2.3. JAPAN
          • 6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.3.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.3.3. KEY CONCLUSIONS
        • 6.4.3.2.4. AUSTRALIA
          • 6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.4.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.4.3. KEY CONCLUSIONS
        • 6.4.3.2.5. REST OF ASIA PACIFIC
          • 6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.5.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.5.3. KEY CONCLUSIONS
    • 6.4.4. ROW
      • 6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.4.2. TOP COUNTRY ANALYSIS
        • 6.4.4.2.1. LATIN AMERICA
          • 6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.4.2.1.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.4.2.1.3. KEY CONCLUSIONS
        • 6.4.4.2.2. MIDDLE EAST & AFRICA
          • 6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.4.2.2.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.4.2.2.3. KEY CONCLUSIONS

7. COMPANY PROFILES

  • 7.1. ACAMP (CANADA)
    • 7.1.1. OVERVIEW
    • 7.1.2. PRODUCT PORTFOLIO
    • 7.1.3. STRATEGIC INITIATIVES
    • 7.1.4. SCOT ANALYSIS
    • 7.1.5. STRATEGIC ANALYSIS
  • 7.2. BIO-IMAGES RESEARCH (UNITED KINGDOM)
    • 7.2.1. OVERVIEW
    • 7.2.2. PRODUCT PORTFOLIO
    • 7.2.3. STRATEGIC INITIATIVES
    • 7.2.4. SCOT ANALYSIS
    • 7.2.5. STRATEGIC ANALYSIS
  • 7.3. BOSTON SCIENTIFIC CORPORATION (UNITED STATES)
    • 7.3.1. OVERVIEW
    • 7.3.2. PRODUCT PORTFOLIO
    • 7.3.3. STRATEGIC INITIATIVES
    • 7.3.4. SCOT ANALYSIS
    • 7.3.5. STRATEGIC ANALYSIS
  • 7.4. CAPSOVISION INC. (U.S.)
    • 7.4.1. OVERVIEW
    • 7.4.2. PRODUCT PORTFOLIO
    • 7.4.3. STRATEGIC INITIATIVES
    • 7.4.4. SCOT ANALYSIS
    • 7.4.5. STRATEGIC ANALYSIS
  • 7.5. CERNER (U.S.)
    • 7.5.1. OVERVIEW
    • 7.5.2. PRODUCT PORTFOLIO
    • 7.5.3. STRATEGIC INITIATIVES
    • 7.5.4. SCOT ANALYSIS
    • 7.5.5. STRATEGIC ANALYSIS
  • 7.6. CHONGQING JINSHAN SCIENCE & TECHNOLOGY GROUP CO. LTD. (CHINA)
    • 7.6.1. OVERVIEW
    • 7.6.2. PRODUCT PORTFOLIO
    • 7.6.3. STRATEGIC INITIATIVES
    • 7.6.4. SCOT ANALYSIS
    • 7.6.5. STRATEGIC ANALYSIS
  • 7.7. FUJIFILM HOLDINGS CORPORATION (JAPAN)
    • 7.7.1. OVERVIEW
    • 7.7.2. PRODUCT PORTFOLIO
    • 7.7.3. STRATEGIC INITIATIVES
    • 7.7.4. SCOT ANALYSIS
    • 7.7.5. STRATEGIC ANALYSIS
  • 7.8. GE HEALTHCARE (UK)
    • 7.8.1. OVERVIEW
    • 7.8.2. PRODUCT PORTFOLIO
    • 7.8.3. STRATEGIC INITIATIVES
    • 7.8.4. SCOT ANALYSIS
    • 7.8.5. STRATEGIC ANALYSIS
  • 7.9. GIVEN IMAGING INC. (ISRAEL)
    • 7.9.1. OVERVIEW
    • 7.9.2. PRODUCT PORTFOLIO
    • 7.9.3. STRATEGIC INITIATIVES
    • 7.9.4. SCOT ANALYSIS
    • 7.9.5. STRATEGIC ANALYSIS
  • 7.10. INTROMEDIC CO. LTD. (SOUTH KOREA)
    • 7.10.1. OVERVIEW
    • 7.10.2. PRODUCT PORTFOLIO
    • 7.10.3. STRATEGIC INITIATIVES
    • 7.10.4. SCOT ANALYSIS
    • 7.10.5. STRATEGIC ANALYSIS
  • 7.11. KARL STORZ GMBH & CO. KG (GERMANY)
    • 7.11.1. OVERVIEW
    • 7.11.2. PRODUCT PORTFOLIO
    • 7.11.3. STRATEGIC INITIATIVES
    • 7.11.4. SCOT ANALYSIS
    • 7.11.5. STRATEGIC ANALYSIS
  • 7.12. MEDIMETRICS (MEXICO)
    • 7.12.1. OVERVIEW
    • 7.12.2. PRODUCT PORTFOLIO
    • 7.12.3. STRATEGIC INITIATIVES
    • 7.12.4. SCOT ANALYSIS
    • 7.12.5. STRATEGIC ANALYSIS
  • 7.13. OLYMPUS CORPORATION (JAPAN)
    • 7.13.1. OVERVIEW
    • 7.13.2. PRODUCT PORTFOLIO
    • 7.13.3. STRATEGIC INITIATIVES
    • 7.13.4. SCOT ANALYSIS
    • 7.13.5. STRATEGIC ANALYSIS
  • 7.14. PENTAX MEDICAL COMPANY (U.S.)
    • 7.14.1. OVERVIEW
    • 7.14.2. PRODUCT PORTFOLIO
    • 7.14.3. STRATEGIC INITIATIVES
    • 7.14.4. SCOT ANALYSIS
    • 7.14.5. STRATEGIC ANALYSIS
  • 7.15. PROTEUS DIGITAL HEALTH INC. (U.S.)OVERVIEW
    • 7.15.1. PRODUCT PORTFOLIO
    • 7.15.2. STRATEGIC INITIATIVES
    • 7.15.3. SCOT ANALYSIS
    • 7.15.4. STRATEGIC ANALYSIS

LIST OF TABLES

  • 1. GLOBAL SMART PILL MARKET BY APPLICATION 2014-2023 ($ MILLION)
  • 2. GLOBAL CAPSULE ENDOSCOPY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 3. GLOBAL DRUG DELIVERY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 4. GLOBAL PATIENT MONITORING MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 5. NORTH AMERICA SMART PILL MARKET 2014-2023 ($ MILLION)
  • 6. EUROPE SMART PILL MARKET 2014-2023 ($ MILLION)
  • 7. ASIA PACIFIC SMART PILL MARKET 2014-2023 ($ MILLION)
  • 8. REST OF THE WORLD SMART PILL MARKET 2014-2023 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL CAPSULE ENDOSCOPY MARKET 2014-2023 ($ MILLION)
  • 2. GLOBAL DRUG DELIVERY MARKET 2014-2023 ($ MILLION)
  • 3. GLOBAL PATIENT MONITORING MARKET 2014-2023 ($ MILLION)
  • 4. UNITED STATES (U.S.) SMART PILL MARKET 2014-2023 ($ MILLION)
  • 5. CANADA SMART PILL MARKET 2014-2023 ($ MILLION)
  • 6. UNITED KINGDOM (UK) SMART PILL MARKET 2014-2023 ($ MILLION)
  • 7. FRANCE SMART PILL MARKET 2014-2023 ($ MILLION)
  • 8. GERMANY SMART PILL MARKET 2014-2023 ($ MILLION)
  • 9. SPAIN SMART PILL MARKET 2014-2023 ($ MILLION)
  • 10. ROE SMART PILL MARKET 2014-2023 ($ MILLION)
  • 11. INDIA SMART PILL MARKET 2014-2023 ($ MILLION)
  • 12. CHINA SMART PILL MARKET 2014-2023 ($ MILLION)
  • 13. JAPAN SMART PILL MARKET 2014-2023 ($ MILLION)
  • 14. AUSTRALIA SMART PILL MARKET 2014-2023 ($ MILLION)
  • 15. ROAPAC SMART PILL MARKET 2014-2023 ($ MILLION)
  • 16. LATIN AMERICA SMART PILL MARKET 2014-2023 ($ MILLION)
  • 17. MENA SMART PILL MARKET 2014-2023 ($ MILLION)
Back to Top